Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 2.22
(0.45%)
CNY 2.22
(0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.82 Billion | 13.03 Billion | 9.86 Billion | 5.26 Billion | 5.96 Billion | 6 Billion |
| Cost of Revenue | 6.87 Billion | 7.45 Billion | 5.72 Billion | 4.27 Billion | 4.6 Billion | 4.68 Billion |
| Gross Profit | 1.94 Billion | 5.58 Billion | 4.13 Billion | 988.8 Million | 1.35 Billion | 1.32 Billion |
| Operating Expenses | 459.06 Million | 1.04 Billion | 486.11 Million | 457.93 Million | 688.68 Million | 686.47 Million |
| Selling, General and Administrative Expenses | 404.21 Million | 126 Million | 117.73 Million | 145.88 Million | 349.26 Million | 423.9 Million |
| Research and Development Expenses | 47.34 Million | 67.93 Million | 33.31 Million | 39.67 Million | 38.3 Million | 31.14 Million |
| Other Expenses | -31.3 Million | 853.75 Million | 335.06 Million | 272.37 Million | 301.12 Million | 1.73 Million |
| Cost and Expenses | 7.28 Billion | 8.49 Billion | 6.21 Billion | 4.72 Billion | 5.29 Billion | 5.36 Billion |
| Operating Income | 1.54 Billion | 4.48 Billion | 3.59 Billion | 92 Million | 582.66 Million | 413.95 Million |
| Interest Expense | 24.37 Million | 51.43 Million | 77.81 Million | 82.16 Million | 57.04 Million | 58.31 Million |
| Income Tax Expense | 257.26 Million | 668.32 Million | 551.87 Million | 12.89 Million | 77.14 Million | 117.48 Million |
| Earnings before Tax | 1.53 Billion | 4.47 Billion | 3.58 Billion | 15.8 Million | 583.75 Million | 415.69 Million |
| Net Income | 1.28 Billion | 3.8 Billion | 3.01 Billion | 2.9 Million | 516.85 Million | 363.08 Million |
| Earnings Per Share Basic | 0.15 | 0.44 | 0.36 | 0.00 | 0.06 | 0.04 |
| Earnings Per Share Diluted | 0.15 | 0.44 | 0.36 | 0.00 | 0.06 | 0.04 |
| Weighted Average Shares Outstanding | 8.7 Billion | 8.69 Billion | 8.43 Billion | 8.52 Billion | 8.65 Billion | 8.83 Billion |
| Weighted Average Shares Outstanding (Diluted) | 8.7 Billion | 8.69 Billion | 8.43 Billion | 8.52 Billion | 8.65 Billion | 9.07 Billion |
| Gross Margin | 0.22 | 0.43 | 0.42 | 0.19 | 0.23 | 0.22 |
| EBIT Margin | 0.29 | 0.42 | 0.44 | 0.14 | 0.22 | 0.20 |
| Profit Margin | 0.15 | 0.29 | 0.31 | 0.00 | 0.09 | 0.06 |
| EBITDA | 2.51 Billion | 5.44 Billion | 4.3 Billion | 743.69 Million | 1.27 Billion | 1.04 Billion |
| Earnings Before Tax Margin | 0.17 | 0.34 | 0.36 | 0.02 | 0.10 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.95 Billion | 2.82 Billion | 1.98 Billion | 2.36 Billion | 8.75 Billion | 2.34 Billion |
| Cost of Revenue | 1.77 Billion | 2.53 Billion | 1.79 Billion | 1.91 Billion | 6.87 Billion | 1.76 Billion |
| Gross Profit | 174.24 Million | 284.03 Million | 190.46 Million | 455.15 Million | 1.87 Billion | 582.21 Million |
| Operating Expenses | 143.74 Million | 79.27 Million | 145.8 Million | 184.11 Million | 459.06 Million | 127.17 Million |
| Selling, General and Administrative Expenses | 133.41 Million | 73.09 Million | 137.46 Million | 135.86 Million | - | 244.77 Million |
| Research and Development Expenses | 7.72 Million | 2.26 Million | 8.34 Million | 11.49 Million | - | 10.53 Million |
| Other Expenses | -2.6 Million | -3.92 Million | -3596.83 | -36.75 Million | -31.3 Million | -50.41 Thousand |
| Cost and Expenses | 1.92 Billion | 2.61 Billion | 1.94 Billion | 2.09 Billion | 7.33 Billion | 1.88 Billion |
| Operating Income | 30.5 Million | 204.75 Million | 44.65 Million | 271.04 Million | 1.42 Billion | 481.05 Million |
| Interest Expense | 23.34 Million | 20.82 Million | 16.27 Million | -17.7 Million | 24.37 Million | 14.94 Million |
| Income Tax Expense | 6.69 Million | 40.8 Million | 16.46 Million | 61.5 Million | 257.26 Million | 70.06 Million |
| Earnings before Tax | 14.64 Million | 201.71 Million | 43.6 Million | 320.22 Million | 1.48 Billion | 481 Million |
| Net Income | 29.04 Million | 162.47 Million | 29.79 Million | 264.19 Million | 1.28 Billion | 402.51 Million |
| Earnings Per Share Basic | 0.00 | 0.02 | 0.00 | 0.03 | - | 0.05 |
| Earnings Per Share Diluted | 0.00 | 0.02 | 0.00 | 0.03 | - | 0.05 |
| Weighted Average Shares Outstanding | 8.06 Billion | 8.28 Billion | 8.72 Billion | 8.63 Billion | 8.7 Billion | 8.72 Billion |
| Weighted Average Shares Outstanding (Diluted) | 8.06 Billion | 8.28 Billion | 8.72 Billion | 8.63 Billion | 8.7 Billion | 8.72 Billion |
| Gross Margin | 0.09 | 0.10 | 0.10 | 0.19 | 0.21 | 0.25 |
| EBIT Margin | 0.02 | 0.16 | 0.04 | 0.22 | - | 0.20 |
| Profit Margin | 0.01 | 0.06 | 0.01 | 0.11 | 0.15 | 0.17 |
| EBITDA | 37.98 Million | 453.16 Million | 74.45 Million | 530.65 Million | - | 476.71 Million |
| Earnings Before Tax Margin | 0.02 | 0.07 | 0.02 | 0.11 | 0.16 | 0.21 |
PREMIERPOL
CAPR
HUMANSOFT
NNOCF
PXMBF
RAMCOIND